FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078009464> ?p ?o ?g. }

• W2078009464 endingPage "0" @default.
• W2078009464 startingPage "0" @default.
• W2078009464 abstract "Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas David B. Smith1, John P. Neoptolemos21Clatterbridge Centre for Oncology, Bebington, Wirral, UK; 2School of Cancer Studies, University of Liverpool, Liverpool, UKIntroduction: More than 90% of patients with pancreatic cancer present either with incurable locally advanced or metastatic disease or relapse following surgery. For these patients systemic therapy offers the only prospect of salvage, but pancreatic cancer is one of the most chemoresistant of tumors; current chemotherapy can only delay progression in a limited proportion of patients and survival rates are poor. There is therefore a pressing need for more effective therapy. Capecitabine is a new oral prodrug of fluorouracil, which has shown activity in pancreatic cancer particularly when used in combination with gemcitabine.Aims: To review the emerging evidence for the clinical effectiveness of capecitabine in the management of carcinoma of the pancreas.Evidence review: There is evidence from phase II testing that capecitabine is active in pancreatic cancer. The Swiss Group for Clinical Cancer Research/Central European Cooperative Oncology Group (SAKK/CECOG) phase III trial found that the combination of gemcitabine and capecitabine did not improve overall median survival as compared with gemcitabine alone (8.4 vs 7.3 months, respectively; P=0.314) but subgroup analysis in patients with good performance score [Karnofsky Performance Scores (KPS) ³90] revealed a significant survival improvement with the combination arm (10.1 months) compared with single-agent gemcitabine (7.5 months; P=0.033). Preliminary data from the GemCap phase III trial indicated significantly improved response rates and survival for the combination of gemcitabine with capecitabine (7.4 months) compared with gemcitabine alone (6 months; P=0.026) but analysis of the mature data with adequate follow-up awaits reporting.Clinical potential: The addition of capecitabine to gemcitabine may represent a small step forward in the management of advanced pancreatic cancer but further data are required in order to determine its full impact.Key words: adjuvant, advanced, cancer, capecitabine, chemotherapy, gemcitabine, pancreas, pancreatic" @default.
• W2078009464 created "2016-06-24" @default.
• W2078009464 creator A5052825850 @default.
• W2078009464 creator A5080168198 @default.
• W2078009464 date "2007-12-01" @default.
• W2078009464 modified "2023-10-16" @default.
• W2078009464 title "Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas" @default.
• W2078009464 cites W156810664 @default.
• W2078009464 cites W1849818006 @default.
• W2078009464 cites W1931508686 @default.
• W2078009464 cites W1964717481 @default.
• W2078009464 cites W1976453303 @default.
• W2078009464 cites W2009470129 @default.
• W2078009464 cites W2025970479 @default.
• W2078009464 cites W2026420492 @default.
• W2078009464 cites W2027451548 @default.
• W2078009464 cites W2030395635 @default.
• W2078009464 cites W2032561957 @default.
• W2078009464 cites W2042576306 @default.
• W2078009464 cites W2042653326 @default.
• W2078009464 cites W2044852666 @default.
• W2078009464 cites W2044970916 @default.
• W2078009464 cites W2051976727 @default.
• W2078009464 cites W2074763653 @default.
• W2078009464 cites W2084330540 @default.
• W2078009464 cites W2084562398 @default.
• W2078009464 cites W2086426432 @default.
• W2078009464 cites W2097635599 @default.
• W2078009464 cites W2108146474 @default.
• W2078009464 cites W2126119745 @default.
• W2078009464 cites W2127762172 @default.
• W2078009464 cites W2129197203 @default.
• W2078009464 cites W2131368686 @default.
• W2078009464 cites W2132356244 @default.
• W2078009464 cites W2135352785 @default.
• W2078009464 cites W2140626944 @default.
• W2078009464 cites W2143333875 @default.
• W2078009464 cites W2146161922 @default.
• W2078009464 cites W2147400554 @default.
• W2078009464 cites W2150000081 @default.
• W2078009464 cites W2151767652 @default.
• W2078009464 cites W2152511454 @default.
• W2078009464 cites W2158079979 @default.
• W2078009464 cites W2158134441 @default.
• W2078009464 cites W2170211986 @default.
• W2078009464 cites W2171500698 @default.
• W2078009464 cites W2205384925 @default.
• W2078009464 cites W2246417197 @default.
• W2078009464 cites W2260383083 @default.
• W2078009464 cites W2289397400 @default.
• W2078009464 cites W2413080121 @default.
• W2078009464 doi "https://doi.org/10.2147/ce.s7426" @default.
• W2078009464 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3012429" @default.
• W2078009464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21221179" @default.
• W2078009464 hasPublicationYear "2007" @default.
• W2078009464 type Work @default.
• W2078009464 sameAs 2078009464 @default.
• W2078009464 citedByCount "0" @default.
• W2078009464 crossrefType "journal-article" @default.
• W2078009464 hasAuthorship W2078009464A5052825850 @default.
• W2078009464 hasAuthorship W2078009464A5080168198 @default.
• W2078009464 hasBestOaLocation W20780094641 @default.
• W2078009464 hasConcept C121608353 @default.
• W2078009464 hasConcept C126322002 @default.
• W2078009464 hasConcept C143998085 @default.
• W2078009464 hasConcept C2776694085 @default.
• W2078009464 hasConcept C2777909004 @default.
• W2078009464 hasConcept C2780210213 @default.
• W2078009464 hasConcept C2780258809 @default.
• W2078009464 hasConcept C526805850 @default.
• W2078009464 hasConcept C71924100 @default.
• W2078009464 hasConceptScore W2078009464C121608353 @default.
• W2078009464 hasConceptScore W2078009464C126322002 @default.
• W2078009464 hasConceptScore W2078009464C143998085 @default.
• W2078009464 hasConceptScore W2078009464C2776694085 @default.
• W2078009464 hasConceptScore W2078009464C2777909004 @default.
• W2078009464 hasConceptScore W2078009464C2780210213 @default.
• W2078009464 hasConceptScore W2078009464C2780258809 @default.
• W2078009464 hasConceptScore W2078009464C526805850 @default.
• W2078009464 hasConceptScore W2078009464C71924100 @default.
• W2078009464 hasLocation W20780094641 @default.
• W2078009464 hasLocation W20780094642 @default.
• W2078009464 hasOpenAccess W2078009464 @default.
• W2078009464 hasPrimaryLocation W20780094641 @default.
• W2078009464 hasRelatedWork W1988326884 @default.
• W2078009464 hasRelatedWork W2007621813 @default.
• W2078009464 hasRelatedWork W2036431530 @default.
• W2078009464 hasRelatedWork W2036821810 @default.
• W2078009464 hasRelatedWork W2139955290 @default.
• W2078009464 hasRelatedWork W2184836338 @default.
• W2078009464 hasRelatedWork W2331476054 @default.
• W2078009464 hasRelatedWork W2376347278 @default.
• W2078009464 hasRelatedWork W2419408601 @default.
• W2078009464 hasRelatedWork W4236454882 @default.
• W2078009464 isParatext "false" @default.
• W2078009464 isRetracted "false" @default.
• W2078009464 magId "2078009464" @default.
• W2078009464 workType "article" @default.